Hedge funds and private equity firms are jumping into another aspect of litigation finance with loans that finance mass tort cases against drug companies and medical device manufacturers. One hedge fund getting involved is EJF Capital, which hopes to raise an additional $300 million for an investment vehicle for mass tort cases, the New York Times reports.

Read the source article at abajournal.com